)

Control Print (522295) investor relations material
Control Print Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Q1 FY26 standalone revenue reached INR 109 crores, up from INR 89 crores in Q1 last year, with consolidated operating revenue at INR 111 crores versus INR 98 crores year-over-year.
Achieved highest ever Q1 standalone revenue of Rs 1,005 mn, up 14% year-over-year, with consolidated revenue at Rs 1,112.9 mn, up 13.75% year-over-year.
Exceptional income of INR 3.99 crores (Rs 399.03 lakhs) recognized as a capital subsidy for the mask lab/division, representing 30% of investment in power and machinery.
Management acknowledged Q1 results were disappointing but reaffirmed commitment to ongoing business transformation and long-term growth.
Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, with limited review by statutory auditors and no modifications in their reports.
Financial highlights
Standalone Q1 operating revenue: INR 100 crores (vs. INR 88 crores last year); consolidated Q1 operating revenue: INR 111 crores (vs. INR 98 crores last year).
Standalone Q1FY26 EBITDA margin at 22.06%, down from 26.54% in Q1FY25; consolidated EBITDA margin at 16.7%, down from 20.91% year-over-year.
Standalone net profit for the quarter was ₹2,126.43 lakhs, compared to ₹1,620.12 lakhs in the same quarter last year; consolidated net profit was ₹856.46 lakhs, down from ₹1,165.55 lakhs.
EBITDA declined from INR 20 crores to INR 18.5 crores year-over-year at the consolidated level, mainly due to losses in the packaging business.
Standalone PAT margin rose to 31.25% (Q1FY26) from 18.37% (Q1FY25) due to exceptional income; consolidated PAT margin at 7.7%, down from 11.91%.
Outlook and guidance
Management expects packaging business losses to reduce, targeting breakeven by Q3/Q4 FY26 and annual loss under INR 10 crores.
Coding and marking business expected to grow at 15% annually for the next 2-3 years; price increases effective August should improve margins from Q3.
Plans to drive exponential growth through new product launches, acquisitions, and increased focus on high-volume customers.
Track & Trace business expected to grow, supported by government mandates for top 1000 drugs.
No formal consolidated revenue or EBITDA margin guidance provided; management expects improvement as new businesses scale.
Next Control Print earnings date

Next Control Print earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage